• Published On : Nov-2016 |
  • Pages : 168 Pages |
  • Format :

1. Executive Summary

2. Assumptions and Acronyms

3. Research Methodology

4. Hepatitis C Treatment Market Overview
   4.1. Introduction
        4.1.1. Hepatitis C Treatment Market Definition
        4.1.2. Hepatitis C Treatment Market – Current treatment options
        4.1.3. Hepatitis C Treatment Market Taxonomy
        4.1.4. Hepatitis C Treatment Market – Parent Market Overview
   4.2. Hepatitis C Treatment Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Opportunity
   4.3. Pipeline Analysis
   4.4. Disease Epidemiology, By Region

5. Global Hepatitis C Treatment Market Analysis Scenario
   5.1. Market Value (US$ Mn) Forecast
        5.1.1. Y-o-Y Growth Projections
        5.1.2. Absolute $ Opportunity
   5.2. Hepatitis C Treatment Market Trends
   5.3. Regional Average Pricing Analysis (2015)
   5.4. Global Hepatitis C Treatment Market Snapshot (2015)
        5.4.1. Market Share, By Region
        5.4.2. Market Share, By Drug Class 
        5.4.3. Market Share, By Distribution Channel 

6. Global Hepatitis C Treatment Market Analysis, By Drug Class 
   6.1. Introduction
        6.1.1. Y-o-Y Growth Comparison, By Drug Class 
        6.1.2. Market Share & Basis Point (BPS) Analysis, By Drug Class 
   6.2. Market Forecast, By Drug Class 
        6.2.1. HCV Protease Inhibitors
               6.2.1.1. Absolute $ Opportunity
               6.2.1.2. Market Value (US$ Mn) Forecast
        6.2.2. HCV Polymerase Inhibitors
               6.2.2.1. Absolute $ Opportunity
               6.2.2.2. Market Value (US$ Mn) Forecast
        6.2.3. HCV NS5A Inhibitors
               6.2.3.1. Absolute $ Opportunity
               6.2.3.2. Market Value (US$ Mn) Forecast
        6.2.4. Combination Therapy
               6.2.4.1. Absolute $ Opportunity
               6.2.4.2. Market Value (US$ Mn) Forecast
               6.2.4.3. Ledipasvir & Sofosbuvir
               6.2.4.4. Ombitasvir, Paritaprevir, Ritonavir & Dasabuvir
               6.2.4.5. Elbasvir & Grazoprevir
               6.2.4.6. Others
        6.2.5. Interferon and Antiviral
               6.2.5.1. Absolute $ Opportunity
               6.2.5.2. Market Value (US$ Mn) Forecast
               6.2.5.3. Peginterferon alfa-2a
               6.2.5.4. Peginterferon alfa-2b
               6.2.5.5. Ribavirin
               6.2.5.6. Others
   6.3. Market Attractiveness Analysis, By Drug Class 
   6.4. Prominent Trends

7. Global Hepatitis C Treatment Market Analysis, By Distribution Channel 
   7.1. Introduction
        7.1.1. Y-o-Y Growth Comparison, By Distribution Channel 
        7.1.2. Market Share & Basis Point (BPS) Analysis, By Distribution Channel 
   7.2. Market Forecast, By Distribution Channel 
        7.2.1. Hospital Pharmacies
               7.2.1.1. Absolute $ Opportunity
               7.2.1.2. Market Value (US$ Mn) Forecast
        7.2.2. Retail Pharmacies
               7.2.2.1. Absolute $ Opportunity
               7.2.2.2. Market Value (US$ Mn) Forecast
        7.2.3. Online Pharmacies
               7.2.3.1. Absolute $ Opportunity
               7.2.3.2. Market Value (US$ Mn) Forecast

8. Global Hepatitis C Treatment Market Analysis, By Region
   8.1. Introduction
        8.1.1. Y-o-Y Growth Projections, By Region
        8.1.2. Market Share & Basis Point (BPS) Analysis, By Region
   8.2. Market Forecast, By Region
        8.2.1. North America Market Value (US$ Mn) Forecast
        8.2.2. Latin America Market Value (US$ Mn) Forecast
        8.2.3. Europe Market Value (US$ Mn) Forecast
        8.2.4. APAC Market Value (US$ Mn) Forecast
        8.2.5. MEA Market Value (US$ Mn) Forecast
   8.3. Regional Attractiveness Analysis

9. North America Hepatitis C Treatment Market Analysis
   9.1. Introduction
        9.1.1. Y-o-Y Growth Projections, By Country
        9.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   9.2. Key Regulations
   9.3. Key Trends
   9.4. North America Market Forecast
        9.4.1. Market Value (US$ Mn) Forecast, By Country
               9.4.1.1. U.S. Absolute $ Opportunity
               9.4.1.2. Canada Absolute $ Opportunity
        9.4.2. Market Value (US$ Mn) Forecast, By Drug Class 
        9.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
   9.5. Market Attractiveness Analysis
        9.5.1. By Country
        9.5.2. By Drug Class 
        9.5.3. By Distribution Channel 

10. Latin America Hepatitis C Treatment Market Analysis
   10.1. Introduction
        10.1.1. Y-o-Y Growth Projections, By Country
        10.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   10.2. Key Regulations
   10.3. Key Trends
   10.4. Latin America Market Forecast
        10.4.1. Market Value (US$ Mn) Forecast, By Country
               10.4.1.1. Brazil Absolute $ Opportunity
               10.4.1.2. Mexico Absolute $ Opportunity
               10.4.1.3. Rest of Latin America Absolute $ Opportunity
        10.4.2. Market Value (US$ Mn) Forecast, By Drug Class 
        10.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
   10.5. Market Attractiveness Analysis
        10.5.1. By Country
        10.5.2. By Drug Class 
        10.5.3. By Distribution Channel 

11. Europe Hepatitis C Treatment Market Analysis
   11.1. Introduction
        11.1.1. Y-o-Y Growth Projections, By Country
        11.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   11.2. Key Regulations
   11.3. Key Trends
   11.4. Europe Market Forecast
        11.4.1. Market Value (US$ Mn) Forecast, By Country
               11.4.1.1. U.K. Absolute $ Opportunity
               11.4.1.2. France Absolute $ Opportunity
               11.4.1.3. Germany Absolute $ Opportunity
               11.4.1.4. Rest of Europe Absolute $ Opportunity
        11.4.2. Market Value (US$ Mn) Forecast, By Drug Class 
        11.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel 
   11.5. Market Attractiveness Analysis
        11.5.1. By Country
        11.5.2. By Drug Class 
        11.5.3. By Distribution Channel 

12. APAC Hepatitis C Treatment Market Analysis
   12.1. Introduction
        12.1.1. Y-o-Y Growth Projections, By Country
        12.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   12.2. Key Regulations
   12.3. Key Trends
   12.4. APAC Market Forecast
        12.4.1. Market Value (US$ Mn) Forecast, By Country
               12.4.1.1. Japan Absolute $ Opportunity
               12.4.1.2. China Absolute $ Opportunity
               12.4.1.3. Australia & New Zealand Absolute $ Opportunity
               12.4.1.4. Rest of APAC Absolute $ Opportunity
        12.4.2. Market Value (US$ Mn) Forecast, By Drug Class 
        12.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
   12.5. Market Attractiveness Analysis
        12.5.1. By Country
        12.5.2. By Drug Class 
        12.5.3. By Distribution Channel 

13. MEA Hepatitis C Treatment Market Analysis
   13.1. Introduction
        13.1.1. Y-o-Y Growth Projections, By Country
        13.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   13.2. Key Regulations
   13.3. Key Trends
   13.4. MEA Market Forecast
        13.4.1. Market Value (US$ Mn) Forecast, By Country
               13.4.1.1. GCC Countries Absolute $ Opportunity
               13.4.1.2. South Africa Absolute $ Opportunity
               13.4.1.3. Rest of MEA Absolute $ Opportunity
        13.4.2. Market Value (US$ Mn) Forecast, By Drug Class 
        13.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
   13.5. Market Attractiveness Analysis
        13.5.1. By Country
        13.5.2. By Drug Class 
        13.5.3. By Distribution Channel 
        13.5.4. By Disease Indication 

14. Competition Landscape
   14.1. Competition Dashboard
   14.2. Company Profiles Inclusions
        14.2.1. Revenue
        14.2.2. Products/Brand Offerings
        14.2.3. Key developments
        14.2.4. SWOT Analysis
   14.3. Company Profiles
        14.3.1. Gilead Sciences, Inc.
        14.3.2. AbbVie Inc.
        14.3.3. Kadmon Holdings, Inc.
        14.3.4. F. Hoffmann-La Roche Ltd
        14.3.5. GlaxoSmithKline plc.
        14.3.6. Bristol-Myers Squibb Company
        14.3.7. Merck & Co., Inc.
        14.3.8. Johnson & Johnson


List of Tables

Table 1: Global Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016–2024)
Table 2: Global Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016–2024)
Table 3: Global Hepatitis C Treatment Market Size and Forecast by Region (US$ Mn) (2016–2024)
Table 4: North America Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016–2024)
Table 5: North America Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016–2024)
Table 6: North America Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016–2024)
Table 7: Latin America Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016–2024)
Table 8: Latin America Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016–2024)
Table 9: Latin America Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016–2024)
Table 10: Europe Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016–2024)
Table 11: Europe Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016–2024)
Table 12: Europe Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016–2024)
Table 13: APAC Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016–2024)
Table 14: APAC Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016–2024)
Table 15: APAC Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016–2024)
Table 16: MEA Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016–2024)
Table 17: MEA Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016–2024)
Table 18: MEA Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016–2024)


List of Figures

Figure 1: Global Hepatitis C Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2016–2024
Figure 2: Global Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 3: Global Hepatitis C Treatment Market Share and BPS Analysis (%) By Drug Class, 2016 & 2024
Figure 4: Global Hepatitis C Treatment Market Y-o-Y growth (%) By Drug Class, 2016–2024
Figure 5: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By HCV Protease Inhibitors
Figure 6: Global Hepatitis C Treatment Market Absolute $ Opportunity by HCV Protease Inhibitors, 2016–2024
Figure 7: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By HCV Polymerase Inhibitors
Figure 8: Global Hepatitis C Treatment Market Absolute $ Opportunity by HCV Polymerase Inhibitors, 2016–2024
Figure 9: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By HCV NS5A Inhibitors
Figure 10: Global Hepatitis C Treatment Market Absolute $ Opportunity by HCV NS5A Inhibitors, 2016–2024
Figure 11: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Combination Therapy
Figure 12: Global Hepatitis C Treatment Market Absolute $ Opportunity by Combination Therapy, 2016–2024
Figure 13: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Ledipasvir & Sofosbuvir Sub-segment
Figure 14: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Ombitasvir, Paritaprevir, Ritonavir & Dasabuvir Sub-segment
Figure 15: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Elbasvir & Grazoprevir Sub-segment
Figure 16: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Others Sub-segment
Figure 17: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Interferon and Antiviral
Figure 18: Global Hepatitis C Treatment Market Absolute $ Opportunity by Interferon and Antiviral, 2016–2024
Figure 19: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Peginterferon alfa-2a Sub-segment
Figure 20: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Peginterferon alfa-2b Sub-segment
Figure 21: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Ribavirin Sub-segment
Figure 22: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Others Sub-segment
Figure 23: Global Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016–2024
Figure 24: Global Hepatitis C Treatment Market Share and BPS Analysis (%) By Distribution Channel, 2016 & 2024
Figure 25: Global Hepatitis C Treatment Market Y-o-Y growth (%) By Distribution Channel, 2016–2024
Figure 26: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Hospital Pharmacies Segment
Figure 27: Global Hepatitis C Treatment Market Absolute $ Opportunity by Hospital Pharmacies Segment, 2016–2024
Figure 28: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Retail Pharmacies Segment
Figure 29: Global Hepatitis C Treatment Market Absolute $ Opportunity by Retail Pharmacies Segment, 2016–2024
Figure 30: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024) By Online Pharmacies Segment
Figure 31: Global Hepatitis C Treatment Market Absolute $ Opportunity by Online Pharmacies, 2016–2024
Figure 32: Global Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016–2024
Figure 33: North America Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 34: Latin America Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 35: Europe Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 36: APAC Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 37: MEA Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 38: Global Hepatitis C Treatment Market Attractiveness Analysis by Region, 2016–2024
Figure 39: North America Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 40: North America Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016–2024
Figure 41: The U.S Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 42: The U.S Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 43: Canada Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 44: Canada Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 45: North America Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016–2024
Figure 46: North America Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016–2024
Figure 47: North America Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016–2024
Figure 48: Latin America Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 49: Latin America Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016–2024
Figure 50: Brazil Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 51: Brazil Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 52: Mexico Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 53: Mexico Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 54: Rest of Latin America Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 55: Rest of Latin America Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 56: Latin America Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016–2024
Figure 57: Latin America Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016–2024
Figure 58: Latin America Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016–2024
Figure 59: Europe Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 60: Europe Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016–2024
Figure 61: U.K. Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 62: U.K. Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 63: France Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 64: France Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 65: Germany Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 66: Germany Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 67: Rest of Europe Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 68: Rest of Europe Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 69: Europe Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016–2024
Figure 70: Europe Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016–2024
Figure 71: Europe Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016–2024
Figure 72: APAC Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 73: APAC Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016–2024
Figure 74: Japan Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 75: Japan Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 76: China Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 77: China Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 78: Australia & New Zealand Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 79: Australia & New Zealand Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 80: Rest of APAC Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 81: Rest of APAC Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 82: APAC Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016–2024
Figure 83: APAC Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016–2024
Figure 84: APAC Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016–2024
Figure 85: MEA Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 86: MEA Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016–2024
Figure 87: GCC Countries Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 88: GCC Countries Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 89: South Africa Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 90: South Africa Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 91: Rest of MEA Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 92: Rest of MEA Hepatitis C Treatment Market Absolute $ Opportunity, 2016–2024
Figure 93: MEA Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016–2024
Figure 94: MEA Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016–2024
Figure 95: MEA Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016–2024